Fig. 9From: The clinicopathological significance of UBE2C in breast cancer: a study based on immunohistochemistry, microarray and RNA-sequencing dataKaplan–Meier survival analysis for UBE2C expression in BRCA patients from Oncolnc. Kaplan–Meier survival analysis of data from Oncolnc indicated that BRCA patients with lower UBE expression had a better prognosis than BRCA patients with higher UBE2C expression (P = 0.0428)Back to article page